Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-10 Purchase | 2024-01-17 4:03 pm | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 5,000 | $0.67 | $3,350 | 30,000 (Direct) | View |
| 2024-01-12 Purchase | 2024-01-16 8:14 pm | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 2,266 | $0.57589 | $1,305 | 32,266 (Direct) | View |
| 2024-01-05 Purchase | 2024-01-09 5:32 pm | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP of Operations | 10,850 | $0.69 | $7,486 | 1,071,455 (Direct) | View |
| 2024-01-05 Purchase | 2024-01-09 5:31 pm | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 11,600 | $0.69 | $8,004 | 316,740 (Indirect Direct) | View |
| 2024-01-05 Purchase | 2024-01-09 5:30 pm | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 25,054 | $0.66844 | $16,747 | 2,782,615 (Direct) | View |
| 2024-01-05 Purchase | 2024-01-09 5:30 pm | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 7,000 | $0.77 | $5,390 | 37,000 (Direct) | View |
| 2023-08-23 Purchase | 2023-08-31 4:01 pm | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 11,582 | $0.93926 | $10,879 | 1,464,897 (Direct) | View |
| 2023-08-25 Purchase | 2023-08-30 3:15 pm | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 32,644 | $0.92227 | $30,107 | 254,092 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 12,500 | $0 | 22,500 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 10,000 | $10.56 | 22,500 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 3,250 | $0 | 8,950 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 5,700 | $10.56 | 8,950 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 3,250 | $0 | 368,741 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 5,700 | $10.56 | 368,741 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 51,250 | $0 | 330,192 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 148,875 | $7.05 | 330,192 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 3,250 | $0 | 8,950 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 5,700 | $10.56 | 8,950 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP Operations | 20,000 | $0 | 70,531 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP Operations | 10,000 | $10.41 | 70,531 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 3,250 | $0 | 13,161 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 5,700 | $10.56 | 13,161 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 3,250 | $0 | 8,950 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 5,700 | $10.56 | 8,950 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise VP Compliance and Secy | 12,500 | $0 | 64,031 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 5:00 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise VP Compliance and Secy | 1,000 | $10.56 | 64,031 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-10 9:23 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 5,700 | $0 | 8,950 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:29 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 10,000 | $0 | 22,500 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:29 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP of Operations | 5,000 | $0 | 25,000 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:28 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise VP Compliance and Secy | 1,000 | $0 | 13,500 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:28 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 5,700 | $0 | 8,950 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:27 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 28,875 | $0 | 200,125 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:27 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 5,700 | $0 | 8,950 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:26 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 5,700 | $0 | 8,950 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 5:26 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 5,700 | $0 | 8,950 (Direct) | View |
Ownership | 2024-01-17 4:01 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cogley Brian Chief Financial Officer | 0 | $0 | 30,000 (Direct) | View |
| 2023-12-07 Gift | 2023-12-11 4:01 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 700,000 | $0 | 2,757,561 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 11:09 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP of Operations | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 11:05 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise CFO and Secretary | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 11:03 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Salkind Gene Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 10:59 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 625,000 | $0 | 625,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 10:55 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | DeSilva Tara Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 10:53 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Deschamps Philippe Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 10:51 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Cochran Christopher P. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 10:50 am | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Calise Chris Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2022-11-07 2:06 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Yerace Daniel Alexander VP of Operations | 0 | $0 | 1,010,605 (Direct) | View |
Ownership | 2022-11-07 2:01 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Sheehy Christine Elise CFO and Secretary | 0 | $0 | 1,010,605 (Direct) | View |
Ownership | 2022-11-07 1:58 pm | N/A N/A | Coeptis Therapeutics Holdings Inc. | COEP | Mehalick David CEO and President 10% Owner | 0 | $0 | 3,301,311 (Direct) | View |